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Abstract
Background: Gray matter volume studies have been limited to few brain regions of interest, and white matter and glucose
metabolism have received limited research attention in Korsakoff’s syndrome (KS). Because of the lack of brain biomarkers,
KS was found to be underdiagnosed in postmortem studies.
Methodology/Principal Findings: Nine consecutively selected patients with KS and 22 matched controls underwent both
structural magnetic resonance imaging and
18F-fluorodeoxyglucose positron emission tomography examinations. Using a
whole-brain analysis, the between-group comparisons of gray matter and white matter density and relative glucose uptake
between patients with KS and controls showed the involvement of both the frontocerebellar and the Papez circuits,
including morphological abnormalities in their nodes and connection tracts and probably resulting hypometabolism. The
direct comparison of the regional distribution and degree of gray matter hypodensity and hypometabolism within the KS
group indicated very consistent gray matter distribution of both abnormalities, with a single area of significant difference in
the middle cingulate cortex showing greater hypometabolism than hypodensity. Finally, the analysis of the variability in the
individual patterns of brain abnormalities within our sample of KS patients revealed that the middle cingulate cortex was
the only brain region showing significant GM hypodensity and hypometabolism in each of our 9 KS patients.
Conclusions/Significance: These results indicate widespread brain abnormalities in KS including both gray and white
matter damage mainly involving two brain networks, namely, the fronto-cerebellar circuit and the Papez circuit.
Furthermore, our findings suggest that the middle cingulate cortex may play a key role in the pathophysiology of KS and
could be considered as a potential in vivo brain biomarker.
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Introduction
Korsakoff’s syndrome (KS) is marked by global amnesia, which
develops either insidiously or in the wake of Wernicke’s
encephalopathy and whose most common etiology is the
combination of thiamine deficiency and alcoholism [1]. In
addition to severe anterograde amnesia [2], alcoholic Korsakoff’s
syndrome encompasses other neuropsychological impairments,
such as executive dysfunctions [3], retrograde amnesia [1],
visuospatial deficits [4] and ataxia of gait and balance [5].
Postmortem studies of alcoholic Korsakoff patients have shown
pathological abnormalities involving periventricular and periaq-
ueductal gray matter, walls of the third ventricle, floor of the
fourth ventricle and cerebellum [6]. Damage has also been found
in the hippocampus [7], certain nuclei of the thalamus [8,9],
hypothalamus [10] and more particularly the mammillary bodies
[11,12], cerebral cortex [13], brainstem nuclei [14] and locus
coeruleus [15]. Neuroimaging studies using computerized tomog-
raphy have revealed morphological abnormalities, involving
cortical volume reduction, ventricular enlargement, Sylvian fissure
and frontal sulcus widening, wider interhemispheric fissure and
thalamic hypodensity [4,16]. More specifically, magnetic reso-
nance imaging (MRI) has highlighted decreased volume of the
parietal [17] and frontal cortex [17–20], thalamus [3,18,20–23]
and mammillary bodies [3,20,23–25]. Findings in the medial
temporal lobe of patients with KS are more controversial, with the
hippocampus being reported as either preserved [18,26] or
damaged [22,23,27].
These previous MRI investigations, based on the region of
interest (ROI) method, have provided considerable and robust
insight into morphological abnormalities characterizing KS.
However, because they were hypothesis-driven, they only assessed
a fraction of the brain parenchyma and may have missed
abnormalities in regions of the brain which were not examined.
PLoS ONE | www.plosone.org 1 November 2009 | Volume 4 | Issue 11 | e7748Moreover, very few in vivo studies have examined white matter in
this pathology [17,21,28], even though reductions in white matter
volume have been found in neuropathological studies of KS
[13,29], and chronic alcoholism is known to affect white matter
macrostructure [30] and microstructure [31,32]. A voxel-based
(voxel-based morphometry, VBM) examination of both gray and
white matter damage in KS would thus be useful for providing a
comprehensive assessment of the morphological brain alterations
characterizing this syndrome.
Brain abnormalities may also be functional, sometimes involving
remote structures connected to the area of primary damage. In
contrast to structural MRI, positron emission tomography (PET)
represents a means of assessing the dysfunction of neural networks
through measurements of resting cerebral blood flow or glucose
metabolic rate (CMRGlc), which are closely related to synaptic
activity [33]. Using resting fluorodeoxyglucose (FDG) PET
methodology, decreased relative CMRGlc in the anterior and
posterior cingulate cortex and in the precuneus (with a trend for the
thalamus) has already been observed in KS [34]. In another FDG-
PET study [35], the inferior and middle frontal lobes were also
found to be involved, as well as the parietal and orbitofrontal
cortices, though with marginal statistical significance. In this study,
however, FDG uptake was measured during a recognition task,
which may have obscured the hypometabolism pattern by
increasing activity in some cerebral structures relative to the resting
state. In addition, both studies employed the ROI approach, which
provides only limited insight into metabolic brain abnormalities.
Two PET studies have used voxel-based analysis of FDG-PET in
KS[20,36]. InthreeKS patients,Aupe ´e etal. (2001)highlighted the
presence of hypometabolism in the thalamus, posterior cingulate
and mesial frontal cortices, and left supramarginal and middle
temporal gyri. More recently, Reed et al. (2003) reported significant
hypometabolism in the thalamus, medial temporal lobe and
retrosplenial cortex in 12 KS. However, these two voxel-based
studies used low-resolution PET devices ([36]: 5.565.569 mm;
[20]: 8.868.565.5 mm), with a restricted axial field of view ([36]:
81 mm; [20]: 108 mm), which may have missed hypometabolic
foci. Metabolic abnormalities in KS would be localized more
accurately with a voxel-based analysis of data acquired with a high-
resolution scanner and a wider axial field of view.
Although two previous studies have investigated KS by
combining MRI with either single photon emission computed
tomography [37] or PET [20], neither was designed to compare
the location and severity of morphological versus metabolism
abnormalities. And yet, such a direct comparison might offer
evidence for local discrepancies or concordance between morpho-
logical and metabolism abnormalities, as reported in Alzheimer’s
disease [38] and semantic dementia [39] respectively.
Lastly, the existence of invariability in the individual patterns of
brain abnormalities in KS, which could be regarded as a marker of
this disease, is still a matter of debate. Most imaging investigations
have involved group comparisons between KS and controls, and
only a few have examined individual patterns of brain abnormal-
ities. Previous neuropathological and structural imaging investi-
gations have provided conflicting results regarding the role of the
mammillary bodies [40,41] and medio-dorsal thalamus [9,40],
reported by some to be invariably damaged in patients with KS
and by others to be preserved in certain patients. Likewise, glucose
hypometabolism was invariably found in a group of three KS
patients, in the bilateral posterior cingulate and thalamus, left
supramarginal gyrus and bilateral mesial frontal cortex [36]. Thus,
although KS appears to result from the disruption of the Papez
hippocampo-mammillothalamic circuit, an invariant morpholog-
ical and metabolism pattern of abnormalities remains elusive.
The goals of the present study were threefold. Firstly, we aimed
to provide a comprehensive assessment of gray matter (GM) and
white matter (WM) density, as well as glucose metabolism, in a
group of KS patients, using voxel-based analyses. Secondly, we
wanted to compare the distributions and degrees of morphological
and metabolism GM abnormalities using a method specially
designed for this purpose. As hypodensity and hypometabolism do
not have the same units and normative values, we therefore
computed, for each patient, the MRI and PET Z-score maps
relative to normative data obtained from the same sample of
control subjects, and then compared the Z-score maps between the
two modalities. The third goal was to determine a potential in vivo
brain biomarker of KS. To this end, we examined the frequency of
the patterns of morphological and metabolism abnormalities in the
KS sample by using a novel way to use and display the results of
the individual z-score maps.
Results
Between-Group Comparisons
As illustrated in Figure 1A, the analysis revealed significantly
(p,0.001) lower GM density in the KS group than controls
bilaterally in the cerebellum, lingual gyrus, fusiform gyrus,
dorsomedian thalamus, hypothalamus (particularly the mammil-
lary bodies), median and superior orbitofrontal cortex, superior
and middle frontal cortex, supplementary motor area, anterior
and middle cingulate cortex, cuneus, precuneus and paracentral
lobule, left superior temporal gyrus, Heschl’s gyrus, insula,
supramarginal gyrus, and right postcentral and precentral gyri.
When a less stringent FDR-corrected p-value cut-off of ,0.005
was applied, the bilateral hippocampal, parahippocampal and
posterior cingulate cortices were also identified with lower GM
density in KS than controls.
Regarding WM density, significant (p,0.001) decreases in-
volved the genu and body of the corpus callosum, the cerebellar
WM and the pontine and mesencephalic WM in the KS group
compared with controls (Figure 1B). Using a less stringent FDR-
corrected p-value cut-off of ,0.005, the superior part of the fornix
and the inferior part of the cingulum bundle were also implicated
bilaterally.
Significant hypometabolism in KS was present bilaterally and
involved the calcarine cortex, lingual gyrus, middle occipital gyrus,
thalamus, mammillary bodies, median orbitofrontal cortex,
superior middle frontal cortex, supplementary motor area, whole
cingulate cortex, cuneus, precuneus and paracentral lobule, as well
as the left middle and inferior temporal lobe. Using a less stringent
FDR-corrected p-value cut-off of ,0.005, significant abnormalities
were also observed in the bilateral hippocampal and left
parahippocampal areas (Figure 1C).
Within-Group Analysis
The direct SPM comparison between MRI and PET z-scores
(including only voxels with group mean Z-MRI and/or Z-PET
,21.725) is illustrated in Figure 2. The GM hypodensity.hypo-
metabolism contrast highlighted the cerebellum and fusiform
gyrus bilaterally (Figure 2A), while the reverse GM hypometabo-
lism.hypodensity contrast revealed a single cluster in the middle
cingulate cortex (Figure 2B).
Individual Patterns
The middle cingulate gyrus was the only structure showing
significant GM hypodensity in all 9 KS patients (Figure 3A). No
consistent WM abnormality was found (Figure 3B), while
consistent hypometabolism was found to involve the middle
Brain Imaging in Amnesia
PLoS ONE | www.plosone.org 2 November 2009 | Volume 4 | Issue 11 | e7748Figure 1. GM (A), WM (B), and metabolism (C) abnormalities in Korsakoff’s syndrome compared with healthy subjects (k.200
voxels). Between group comparisons conducted with the SPM5 two-sample t-test routine. False Discovery Rate correction. On the coronal slice, the
right is displayed on the right. The colored bar represents the t value of significant voxels.
doi:10.1371/journal.pone.0007748.g001
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patients (Figure 3C).
Discussion
This study revealed widespread morphological and metabolism
abnormalities in KS patients, but two networks appeared to be
particularly impaired, namely the frontocerebellar and Papez circuits.
Moreover, the middle cingulate cortex, which belongs to the Papez
circuit, seemed to play a key role in the neuropathology of KS.
Frontocerebellar Circuit
Our findings are in general agreement with previous studies
reporting GM abnormalities in the frontal lobes [17,20], cerebellum
[5,41] and thalamus [18,20,23] and glucose hypometabolism in the
frontal lobes and thalamus [20,36]. Our study also revealed WM
hypodensity in cerebellar, pontine and mesencephalic WM. Taken
together, these findings suggest changes to the main nodes and
connections of the frontocerebellar circuitry linking the frontal
cortex to the thalamus and cerebellum via the ventral pons [42,43].
Disruption of this circuit may be related, or lead to, both the gait
and balance deficits [5] and some of the cognitive impairments
(executive functions and working memory) observed in KS [2].
A comparison of morphological and metabolism abnormalities
showed that GM hypodensity was significantly greater than
hypometabolism in the cerebellar hemispheres, suggesting the
relative metabolic preservation of these structures. This finding is
in agreement with a previous report indicating that the severity of
morphological abnormalities does not correlate with local metabolic
rates in the cerebellum in uncomplicated alcoholism [44], possibly
reflecting compensatory mechanisms within the frontocerebellar
circuit [45]. Our findings in the cerebellum need, however, to be
interpreted with caution, as the fact we used the vermis, a region
adjoining the cerebellar hemispheres, as reference for the quantita-
tive normalization of PET data may have influenced these results.
Lastly, abnormalities in the pontine and mesencephalic fibers
were suggestive of the presence of a subclinical form of central
pontine myelinolysis in KS, as has already been noted in
uncomplicated alcoholism [46]. The same hypothesis may be
established regarding the corpus callosum and the existence of a
subclinical form of Marchiafava-Bignami disease in KS [47].
Papez Circuit
We found significantly lower GM density in the thalamus and
hypothalamus (particularly affecting the mammillary bodies) of KS
than controls, which is in agreement with neuropathological data
[9,13,48,49] and previous MRI investigations using the ROI approach
[18,20,23,41,50]. We also found hippocampal and parahippocampal
GM hypodensity, confirming the presence of medial temporal
abnormalities in KS [22,23,27]. In addition to morphological
abnormalities in the nodes of the Papez circuit, our study revealed
disruption of connectivity, involving the superior part of the fornix and
inferior part of the cingulum bundle, leading to disconnections between
the cingulate gyri, hippocampi and mammillary bodies.
The morphological damage to the nodes and connections of the
Papez circuit may have caused synaptic dysfunction, as revealed
by the hypometabolism affecting the thalamus, mammillary
bodies, anterior cingulate cortex, medial temporal lobe and, more
precisely, the hippocampus and left parahippocampal cortex
[20,34–36]. This network dysfunction may in turn account for the
severe episodic memory disorders in KS [2,51]. Further studies
using diffusion tensor imaging may reveal a precise pattern in the
fiber bundle damage and circuit disconnection and allow links to
be drawn between microstructural GM and WM changes and
episodic memory impairment in this syndrome.
Lastly, our individual analysis confirms the findings of a number
of previous post-mortem and in vivo imaging studies indicating
that neither morphological [41] nor metabolism [36] abnormal-
ities in the thalamus or the mammillary bodies can be regarded as
brain markers of KS.
Middle Cingulate Cortex
The voxel-by-voxel analysis revealed that the morphological and
metabolism abnormalities were most severe in the cingulate cortex,
especially its middle part. The cingulate cortex has already been shown
Figure 2. Voxel-based comparison between morphological and
metabolism GM abnormalities in Korsakoff’s syndrome
(p,0.01 FDR; k.200 voxels). Within group comparisons conducted
with the SPM5 paired t-test routine, using z-score maps for hypodensity
and hypometabolism. False Discovery Rate correction. On the coronal
slice, the right is displayed on the right. The colored bar represents the t
value of significant voxels.
doi:10.1371/journal.pone.0007748.g002
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PLoS ONE | www.plosone.org 4 November 2009 | Volume 4 | Issue 11 | e7748Figure 3. Variability in the individual patterns of GM (A) and WM (B) hypodensity, and GM hypometabolism (C) in the patients with
Korsakoff’s syndrome. The colored bar represents the variability of the brain abnormalities across the KS sample from present (red) in all 9 KS
patients to absent (black) in all 9 KS.
doi:10.1371/journal.pone.0007748.g003
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disease [38,52]. To our knowledge, the present study is the first to report
morphological damage in this structure in KS, although glucose
hypometabolism there has been already reported [34–36]. Our
findings, showing both morphological and metabolism abnormalities
in the middle cingulate cortex, challenge the hypothesis that the
retrosplenial hypometabolism in KS is entirely secondary to morpho-
logical damage within the diencephalic-limbic memory circuits [20].
However, we also showed that the middle cingulate cortex was the
only structure to exhibit greater hypometabolism than GM hypoden-
sity. This suggests that hypometabolism in this structure may not only
be due to local neuronal damage but may also reflect synaptic
dysfunction remote from morphological damage in other components
of the Papez circuit. Hypometabolism in the cingulate cortex may, in
fact, have preceded the morphological damage there, and may be
related to the harmful effects of alcohol on neurotransmission [53] and
WM integrity [54] within the Papez circuit.
The final aim of the present study was to analyze the variability
of the morphological and metabolism brain abnormalities in KS.
The middle cingulate cortex was the only structure to exhibit both
GM hypodensity and hypometabolism, suggesting that KS, which
is regarded as the prototype of diencephalic amnesia, may be
characterized by this systematic involvement of the cingulate
cortex. Indeed, the middle cingulate cortex may play a key role in
the pathophysiology of KS, given that 1) it was the brain area most
severely affected both morphologically and metabolically, 2) it was
the only brain area to exhibit greater hypometabolism than GM
hypodensity, and 3) it was consistently damaged across the entire
KS sample. The middle cingulate cortex may therefore be
considered as a potential brain biomarker of Korsakoff syndrome,
which would facilitate the in vivo detection of this underdiagnosed
neurological disorder using clinical imaging techniques [11,55,56].
Limitations
This study has certain limitations. Firstly, the present conclu-
sions are based on a relatively small sample of patients, as it is
challenging to collect a larger group of carefully selected KS
patients with both MRI and PET data. Secondly, we used the
MNI template for registration (spatial normalization) and
segmentation instead of a customized template from our samples
of controls and KS patients. While this is the recommended
procedure for samples of less than hundreds of subjects, this may
however lead to reduce the accuracy of the registration process,
particularly for KS patients. We thus checked the accuracy of our
registration process firstly by checking how each individual
registered image matched with the MNI template and each other,
and secondly, by overlaying our results on the mean of the
controls’ and KS patients’ registered images as well as on each
individual KS patients’ registered image. Finally, even though the
present study is the first to highlight the potential existence of an in
vivo brain biomarker in KS, it doesn’t allow us to specify whether
the observed brain abnormalities are related to thiamine
deficiency or chronic alcoholism. Indeed, some of the above-
mentioned morphological and functional abnormalities have also
been described in uncomplicated alcoholism, suggesting graded
effects of brain abnormalities [47]. Further studies, including a
group of uncomplicated alcoholic controls without vitamin
depletion, are required to specify the roles of these two factors.
Materials and Methods
Subjects
Nine patients with KS (5 men and 4 women, age 57.4611.1)
and 22 age- and sex-matched controls (9 men and 13 women, age
60.164.5) were enrolled. None of the participants presented
history of psychiatric or neurological problems (head injury, coma,
epilepsy, depression, etc.). The participants gave their written
informed consent prior to their inclusion in the study, which was
conducted in line with the Declaration of Helsinki and was
approved by the local ethical committee (Comite ´ Consultatif de
Protection des Personnes en Recherche Biome ´dicale de Basse-
Normandie), allowing this study to be conducted in Cyceron
imaging center and Caen University Hospital (CHU).
The KS patients were diagnosed with reference to the DSM IV
[57] criteria of ‘‘Persisting Amnestic Disorder’’ and all met criteria
by chart review for Wernicke’s encephalopathy [58]. Even though
it was difficult to gain an accurate picture of their lifetime alcohol
intake because of the amnesia, they all had a history of heavy
drinking as reported by family members and medical records.
Each patient underwent a detailed neuropsychological examina-
tion comprising assessments of episodic memory, intelligence or
abstract reasoning, and executive functions. Episodic memory was
assessed by means of one or more of the following tests: the
Signoret Memory Battery [59], Rey-Osterrieth Complex Figure
copy and recall [60], the Wechsler Memory Scale [61], the Grober
and Buschke test [62], and the California Verbal Learning Test
[63], which evaluate verbal and visual memory in immediate and
delayed recall. Intelligence or abstract reasoning was assessed by
means of Raven’s Progressive Matrices [64] or by an intelligence
quotient (Beauregard’s IQ, [65]). Lastly, executive functions were
measured using a verbal fluency test [66], the Stroop test [67] or
the Wisconsin Card Sorting Test [68]. All the patients presented
disproportionately severe episodic memory disorders compared
with other cognitive functions and their memory impairments had
social repercussions, in accordance with DSM IV criteria. Indeed,
none of the KS were able to go back to their previous jobs and all
of them lived in sheltered accommodation or were inpatients
waiting for a place in an institution.
Controls were social drinkers as defined by the National
Institute on Alcohol Abuse and Alcoholism [69].
Imaging Data Acquisition
MRI. For each subject, a high-resolution T1-weighted volume
MRI scan was obtained, which consisted of a set of 128 adjacent
axial slices parallel to the AC-PC line, covering the whole brain
and with a 1.5-mm slice thickness and a 0.9460.94-mm pixel size,
using the spoiled gradient echo sequence (TR=10.3 ms;
TE=2.1 ms; FOV=2406180 mm
2; matrix=2566192). All the
MRI datasets were acquired on the same scanner (1.5T Signa
Advantage Echospeed; General Electric), using the same
acquisition protocol.
PET. Subjects also underwent a PET study within days of the
MRI study. Data were acquired using an ECAT Exact HR+
scanner with isotropic resolution of 4.664.264.2 mm and axial
field of view of 158 mm. Subjects were fasted for at least 4 hours
before scanning. To minimize anxiety, the PET procedure was
explained in detail beforehand. The head was positioned on a
headrest relative to the canthomeatal line and gently restrained
with straps.
18FDG uptake was measured in the resting condition,
with eyes closed, in a quiet and dark environment. Subjects were
told to avoid focusing on any specific mental process during
scanning. A catheter was inserted into a vein of the arm to inject
the radiotracer. Following
68Ga transmission scans, 3–5 mci of
18FDG were injected as a bolus at time 0, and a 10-min data
acquisition period started 50 min post-injection. Sixty-three planes
were acquired with septa out (3D acquisition), using a voxel size of
2.262.262.43 mm (x y z). During data acquisition, head motion
was continuously monitored with, and whenever necessary
Brain Imaging in Amnesia
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drawn on the forehead.
Image Processing
The data processing procedure was specifically designed notably
to compare morphological and metabolic data, as previously
described in detail [38,52] and illustrated in Figure 4.
MRI. The MRI data were analyzed using VBM in SPM5, as
described in detail elsewhere [70] and previously used in our
laboratory [71,72]. Briefly, the procedure included segmentation
and registration (spatial normalization) of original MRI datasets
using the default MNI template of SPM5 as priors (the use of a
customized template is not recommended with SPM5 when small
samples are used). Registered MRI data were then smoothed (see
below for details).
PET. The PET data were first corrected for cerebrospinal fluid
(CSF) and WM partial volume effects (PVE), using the voxel-by-
voxel ‘‘modified Mu ¨ller-Gartner’’ method [73,74], described in
detail elsewhere [75], and already used in our laboratory [38,52,71].
All image-processing steps for PVE correction were carried out using
the PVE-lab software [75]. Using SPM5, the PVE-corrected PET
datasets were then coregistered (rigid registration) onto their
respective native MRIs and registered onto MNI, by reapplying
the registration parameters estimated from the VBM protocol
described above. Finally, after smoothing (see below for details), the
resulting PET images were divided by their respective cerebellar
vermis FDG uptake mean value (for the sake of quantitative
normalization) to control for individual variations in the overall PET
value [76]. The vermis was selected as a reference as it had the best-
preserved FDG uptake value in our sample of KS patients relative to
controls (data not shown).
Smoothing
For the between-group comparison and in order to blur
individual variations in gyral anatomy and increase the signal-to-
noise ratio, the registered datasets were smoothed using a 12-mm
Gaussian kernel. The registered PET datasets were also smoothed
(14 mm) before quantitative normalization.
In order to directly compare morphological and metabolism
GM abnormalities, a different Gaussian kernel was applied to the
registered unsmoothed MRI datasets to compensate for the
difference in the original spatial resolution between the two
modalities [77,78]. A 14.6-mm Gaussian kernel was used for the
MRI GM data, resulting in an effective smoothness identical to
PET images smoothed at 14 mm [79].
Masking
The resulting MRI (GM and WM) and PET datasets were
masked so as to include only GM or WM voxels of interest and to
prevent any overlap between the two sets of voxels (see [52] for
details). Briefly, mean images for the GM and WM partitions of the
whole sample (n=31) were created. The WM mask was created by
thresholding the mean WM image above a value of 0.4. A
preliminary GM mask was first obtained by thresholding the mean
GM image above a value of 0.3, while the final GM mask was
created by subtracting the WM mask from the preliminary GM
mask. The resulting binary GM mask was applied to both the GM
and PET datasets, and the binary WM mask to the WM data set.
Z-Score Maps
The smoothed and masked GM, WM and PET images were used
to create z-score maps [(patient individual value-control mean)/
control standard deviation] for each patient and each modality.
Statistical Analysis
Three complementary statistical analyses were performed: 1)
between-group comparisons of GM density, WM density and
FDG uptake (Figure 4A); 2) a within-group comparison between
GM abnormalities and relative hypometabolism (Figure 4B); and
3) an analysis of variability in the individual patterns of GM and
WM density abnormalities and relative hypometabolism across the
KS group (Figure 4C).
Between-group comparisons. Group differences were
assessed by generating maps of statistically significant GM and
WM density abnormalities and hypometabolism in KS patients
relative to controls in three independent analyses with the SPM5
two-sample t-test routine.
Within-group comparisons. Comparisons between the
degrees of morphological and metabolism abnormalities were
only performed for voxels with significant GM hypodensity or
hypometabolism. To this end, mean z-score maps were first
obtained by averaging the GM density and FDG uptake z-score
maps for individuals. A mask image was then created by including
only voxels with the mean MRI(GM) and/or PET z-score ,21.725
(corresponding to the t-value for p (one-tailed) ,0.05, with 20
degrees of freedom i.e. for a control sample size of 22). This mask
was then applied to all individual z-score maps, and the degrees of
GM hypodensity and hypometabolism were compared using the
paired t-test in SPM5 with one group (KS) and two images per
subject, i.e. the masked PET and MRI(GM) z-score maps. Both
contrasts were assessed (Z-PET,Z-MRI(GM) and Z-MRI(GM),Z-
PET) to generate statistical maps reflecting predominant
hypometabolism over GM hypodensity and vice-versa.
Variability of the individual patterns of abnorma-
lities. To highlight interindividual variability in the patterns of
GM and WM density abnormalities and GM hypometabolism in
KS, we computed a map for each modality, displaying the number
of patients with significant hypodensity or hypometabolism in each
voxel. For this purpose, we first thresholded each individual GM,
WM and PET z-score map below 21.725, in order to obtain a
value of ‘1’ in voxels with significant change and a value of 0
elsewhere for each patient’s map. We then added the masked
individual z-score maps for GM, WM and PET images separately.
The three resulting images reflected the frequency (from 0 to 9) in
each voxel of significant GM or WM abnormalities or
hypometabolism in our sample. An invariant pattern, which
could be considered as a brain biomarker, was operationally
defined here as involving all 9 KS patients.
Statistical Threshold and Display of Results
SPM-T maps of GM and WM damage and hypometabolism
were thresholded using an FDR-corrected p-value of ,0.001, with
a minimum cluster size of 200 voxels. This stringent threshold was
selected because lower thresholds highlighted abnormalities across
the whole brain. When relevant, the results were reported using a
less stringent FDR-corrected p-value cut-off of ,0.005. An FDR-
corrected p-value of ,0.01 with a minimum cluster size of 200
voxels was used for the comparison between GM density
abnormalities and hypometabolism. Anatomical localization was
based on the superimposition of SPM-T maps onto the MNI
template using MRIcro [80,81].
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